Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

11

Revenue 2014

AbbVie

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AbbVie's 2013 sales performance.

Belgium's Ablynx enters the US market

Belgium's Ablynx enters the US market

Prior to that he held a number of senior commercial with Sepracor, prior to its acquisition by Dainippon Sumitomo Pharma (DSP) and Solvay Pharmaceuticals, which is now part of AbbVie.

Finalists 2017

by AbbVie. with support from Lucid Group. On Path Patient Support Programme – UK. ... by AbbVie (Dermatology). with support from Lucid Group. On Path Patient Support Programme – UK.

Merck & Co pulls out of hepatitis C R&D as market shrinks

Merck & Co pulls out of hepatitis C R&D as market shrinks And in the interim, the drugs used to treat HCV have largely been produced by Gilead Sciences, with AbbVie and Merck jostling for a distant second place. ... AbbVie meanwhile has seen its first-generation Viekira

Amgen pledges $1.5bn for CytomX preclinical cancer drugs

Amgen pledges $1.5bn for CytomX preclinical cancer drugs Last year, AbbVie agreed a $500m deal for CD71-targeted drugs and two undisclosed targets, while earlier this year Bristol-Myers Squibb (BMS) expanded a 2014 alliance with a $200m upfront ... Two lead candidates from the AbbVie and BMS programmes are

Merck pulls out of hepatitis C R&D as market shrinks

Merck pulls out of hepatitis C R&D as market shrinks And in the interim, the drugs used to treat HCV have largely been produced by Gilead Sciences, with AbbVie and Merck jostling for a distant second place. ... AbbVie meanwhile has seen its first-generation Viekira

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

How Can We Make Payer Communications Really Sing?
With so many different influences at play in access decisions, how can we make sure we tap into what’s really driving payer decision-making. How do we go beyond the stated...
Harnessing the power of core elements to optimise market access
This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...
So how do you really engage with patients?
The most valuable insights from patient engagement are the most unexpected ones. Simple things, which may seem unimportant to you, may be the key to making patients’ lives easier and...

Infographics